Digitoxin is extracted from the leaves of the plant Maodiwa. It is a long-acting cardiac glycoside drug that enhances myocardial contractility, slows heart rate, and inhibits conduction. CD BioGlyco provides tailor-made digitoxin analysis services with our rich experience in Pharmaceutical and Biological Analysis. In addition, digitoxin is often used in various research applications in the form of digitoxin injection and digitoxin tablets, and CD BioGlyco also provides digitoxin injection and digitoxin tablet analysis services to clients.
Fig.1 Digitoxin analysis services. (CD BioGlyco)
Technology: Fluorescence analysis, Molecular dynamics simulation
Journal: Frontiers in Molecular Biosciences
IF: 5
Published: 2023
Results: In this paper, the authors have researched the binding of lysozyme to digitalis toxin and explored the ability of lysozyme to act as a carrier. Upon fluorescence analysis, the authors found that there is a strong interaction between lysozyme and digitalis toxin, which is mainly due to hydrophobic forces. Furthermore, digitalis toxin slightly affected the secondary structure of lysozyme by causing partial unfolding of lysozyme. Preferred binding sites for digitalis toxicosides within lysozyme are the large cavities of the protein. Rather, the authors also utilize molecular docking experiments to determine the primary role of hydrophobic forces in binding. And finally, the authors have calculated and discussed the frontier molecular orbitals for free digitalis toxicoside and complexation with lysozyme. Molecular dynamics simulation studies have shown that the second conformation promotes structural stability, reduces flexibility, and enhances the densification and folding properties of lysozyme compared to the first and third conformations of the digitalis toxin-bound lysozyme complex. Overall, the research suggests that lysozyme can serve as a potential carrier for digitalis toxin in pharmaceutical formulations.
Fig.2 Docking poses of lysozyme with digitoxin: first (A), second (B), and third conformations (C). (Ali, et al., 2023)
CD BioGlyco has rich experience in pharmaceutical analysis and we have a professional research team to provide you with high-quality pharmaceutical analysis services. If you are interested in our services and have any questions, please feel free to contact us.
Reference